Managers
Managers | Title | Age | Since |
---|---|---|---|
William Sibold
PSD | President | - | 18-03-07 |
Joann Nestor
SEC | Corporate Secretary | - | - |
Corporate Officer/Principal | - | - | |
Timothy Harris
PRN | Corporate Officer/Principal | 74 | 17-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
William Sibold
PSD | President | - | 18-03-07 |
Philippe Sauvage
BRD | Director/Board Member | - | 18-03-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 108,223,644 | 107,993,510 ( 99.79 %) | 0 | 99.79 % |
Company contact information
Group companies
Name | Category and Sector |
---|---|
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. |
Pharmaceuticals: Major
|
Sector
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |